Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis

PLoS Medicine

Volumn 15, Issue 12, 2018, Pages

  De Crescenzo, Franco ^a,b,c   Ciabattini, Marco ^d   D’Alò, Gian Loreto ^d   De Giorgi, Riccardo ^a,b   Del Giovane, Cinzia ^e   Cassar, Carolina ^f   Janiri, Luigi ^c   Clark, Nicolas ^g   Ostacher, Michael Joshua ^h,i   Cipriani, Andrea ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF BERN   (Switzerland)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; COCAINE; METHADONE; PSYCHOTROPIC AGENT;

ABSTINENCE; AMPHETAMINE DEPENDENCE; ARTICLE; CANNABIS USE; COCAINE DEPENDENCE; COGNITIVE BEHAVIORAL THERAPY; COMMUNITY REINFORCEMENT APPROACH; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTINGENCY MANAGEMENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; DSM-IV; FOLLOW UP; HUMAN; ICD-10; MANAGEMENT; MEDITATION; META ANALYSIS; METHADONE TREATMENT; OUTCOME ASSESSMENT; OUTPATIENT; PSYCHODYNAMIC PSYCHOTHERAPY; PSYCHOSOCIAL DISORDER; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; URINALYSIS; COMPARATIVE STUDY; NETWORK META-ANALYSIS; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; PSYCHOSOCIAL CARE; TREATMENT OUTCOME;

AMPHETAMINE-RELATED DISORDERS; COCAINE-RELATED DISORDERS; COGNITIVE BEHAVIORAL THERAPY; HUMANS; NETWORK META-ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOSOCIAL SUPPORT SYSTEMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 85059237780     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002715     Document Type: Article

References (87)

1. GBD 2016 DALYs and HALE CollaboratorsGlobal, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–1344. doi: 10.1016/S0140-6736(17)32130-X pmid: 28919118
2. United Nations Office on Drugs and Crime. World drug report 2017. Vienna: United Nations Office on Drugs and Crime; 2017
3. Degenhardt L, Hall W, Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55–70. doi: 10.1016/S0140-6736(11)61138-0 pmid: 22225671
4. Cadet JL, Bisagno V, Neuropsychological consequences of chronic drug use: relevance to treatment approaches. Front Psychiatry. 2016;6:189. doi: 10.3389/fpsyt.2015.00189 pmid: 26834649
5. Atkinson A, Anderson Z, Hughes K, Bellis MA, Sumnall H, Syed Q. Interpersonal violence and illicit drugs. Liverpool: Liverpool John Moores University Centre for Public Health; 2009 [cited 2018 May 24]. http://www.who.int/violenceprevention/interpersonal_violence_and_illicit_drug_use.pdf
6. Kleber HD, Weiss RD, Anton RF, JrGeorge TP, Greenfield SF, Kosten TR, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007;164(4 Suppl):5–123. pmid: 17569411
7. World Health OrganizationmhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings. Version 2.0. Geneva: World Health Organization; 2016 [cited 2018 May 25]. http://apps.who.int/iris/bitstream/10665/250239/1/9789241549790-eng.pdf?ua=1
8. National Institute for Health and Care Excellence. Drug misuse in over 16s: psychosocial interventions (CG51). London: National Institute for Health and Care Excellence; 2016
9. European Monitoring Centre for Drugs and Drug Addiction. Standards and guidelines. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2018 [cited 2018 May 18]. http://www.emcdda.europa.eu/best-practice/guidelines
10. Center for Substance Abuse TreatmentTreatment for stimulant use disorders. Rockville (MD): Substance Abuse and Mental Health Services Administration; 1999
11. Minozzi S, Saulle R, De Crescenzo F, Amato L, Psychosocial interventions for psychostimulant misuse. Cochrane Database Syst Rev. 2016;9:CD011866. doi: 10.1002/14651858.CD011866.pub2 pmid: 27684277
12. Farronato NS, Dursteler-Macfarland KM, Wiesbeck GA, Petitjean SA, A systematic review comparing cognitive-behavioral therapy and contingency management for cocaine dependence. J Addict Dis. 2013;32(3):274–87. doi: 10.1080/10550887.2013.824328 pmid: 24074193
13. Fischer B, Blanken P, Da Silveira D, Gallassi A, Goldner EM, Rehm J, et al. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies. Int J Drug Policy. 2015;26(4):352–63. doi: 10.1016/j.drugpo.2015.01.002 pmid: 25662894
14. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–84. doi: 10.7326/M14-2385 pmid: 26030634
15. Higgins JPT, Green S, Cochrane handbook for systematic reviews of interventions. Version 5.1.0. London: Cochrane Collaboration; 2011 [cited 2018 Nov 20]. https://handbook-5-1.cochrane.org/
16. Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP, Evaluating the quality of evidence from a network meta-analysis. PLoS ONE. 2014;9(7):e99682. doi: 10.1371/journal.pone.0099682 pmid: 24992266
17. University of Bern Institute of Social and Preventive Medicine. CINeMA: Confidence in Network Meta-Analysis. Bern: University of Bern Institute of Social and Preventive Medicine; 2017 [cited 2018 Nov 20]. http://cinema.ispm.ch
18. Kiluk BD, Carroll KM, Duhig A, Falk DE, Kampman K, Lai S, et al. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug Alcohol Depend. 2016;158:1–7. doi: 10.1016/j.drugalcdep.2015.11.004 pmid: 26652899
19. Stata statistical software. Release 13.1. College Station (TX): StataCorp; 2014
20. Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G, Graphical tools for network meta-analysis in STATA. PLoS ONE. 2013;8(10):e76654. doi: 10.1371/journal.pone.0076654 pmid: 24098547
21. Cipriani A, Higgins JP, Geddes JR, Salanti G, Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130–7. doi: 10.7326/0003-4819-159-2-201307160-00008 pmid: 23856683
22. Chaimani A, Mavridis D, Salanti G, A hands-on practical tutorial on performing meta-analysis with Stata. Evid Based Ment Health. 2014;17(4):111–6. doi: 10.1136/eb-2014-101967 pmid: 25288685
23. Dias S, Welton NJ, Caldwell DM, Ades AE, Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7–8):932–44. doi: 10.1002/sim.3767 pmid: 20213715
24. Salanti G, Ades AE, Ioannidis JP, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163–71. doi: 10.1016/j.jclinepi.2010.03.016 pmid: 20688472
25. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F, One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry. 1994;51(12):989–97. doi: 10.1001/archpsyc.1994.03950120061010 pmid: 7979888
26. Carroll KM, Nich C, Ball SA, McCance E, Rounsavile BJ, Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93(5):713–27. doi: 10.1046/j.1360-0443.1998.9357137.x pmid: 9692270
27. Carroll KM, Nich C, Shi JM, Eagan D, Ball SA, Efficacy of disulfiram and twelve step facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial. Drug Alcohol Depend. 2012;126(1–2):224–31. doi: 10.1016/j.drugalcdep.2012.05.019 pmid: 22695473
28. Carroll KM, Kiluk BD, Nich C, Gordon MA, Portnoy GA, Marino DR, et al. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry. 2014;171(4):436–44. doi: 10.1176/appi.ajp.2013.13070987 pmid: 24577287
29. Carroll KM, Nich C, Petry NM, Eagan DA, Shi JM, Ball SA, A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. Drug Alcohol Depend. 2016;160:135–42. doi: 10.1016/j.drugalcdep.2015.12.036 pmid: 26817621
30. Chen KW, Berger CC, Gandhi D, Weintraub E, Lejuez CW, Adding integrative meditation with ear acupressure to outpatient treatment of cocaine addiction: a randomized controlled pilot study. J Altern Complement Med. 2013;19(3):204–10. doi: 10.1089/acm.2011.0311 pmid: 23062020
31. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry. 1999;56(6):493–502. pmid: 10359461
32. Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, et al. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013;44(1):103–14. doi: 10.1016/j.jsat.2012.04.004 pmid: 22657748
33. Dursteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, et al. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription. J Clin Psychopharmacol. 2013;33(1):104–8. pmid: 23277248
34. Epstein DH, Hawkins WE, Covi L, Umbricht A, Preston KL, Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav. 2003;17(1):73–82. doi: 10.1037/0893-164X.17.1.73 pmid: 12665084
35. Festinger DS, Dugosh KL, Kirby KC, Seymour BL, Contingency management for cocaine treatment: cash vs. vouchers. J Subst Abuse Treat. 2014;47(2):168–74. doi: 10.1016/j.jsat.2014.03.001 pmid: 24746956
36. Garcia-Fernandez G, Secades-Villa R, Garcia-Rodriguez O, Sanchez-Hervas E, Fernandez-Hermida JR, Higgins ST, Adding voucher-based incentives to community reinforcement approach improves outcomes during treatment for cocaine dependence. Am J Addict. 2011;20(5):456–61. doi: 10.1111/j.1521-0391.2011.00154.x pmid: 21838845
37. Garcia-Rodriguez O, Secades-Villa R, Alvarez Rodriguez H, Río Rodríguez A, Fernández-Hermida JR, Carballo JL, et al. [Effect of incentives on retention in an outpatient treatment for cocaine addicts.] Psicothema. 2007;19(1):134–9. pmid: 17295995
38. Ghitza UE, Epstein DH, Schmittner J, Vahabzadeh M, Lin JL, Preston KL, Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. J Consult Clin Psychol. 2007;75(5):765–74. doi: 10.1037/0022-006X.75.5.765 pmid: 17907858
39. Hagedorn HJ, Noorbaloochi S, Simon AB, Bangerter A, Stitzer ML, Stetler CB, et al. Rewarding early abstinence in Veterans Health Administration addiction clinics. J Subst Abuse Treat. 2013;45(1):109–17. doi: 10.1016/j.jsat.2013.01.006 pmid: 23453480
40. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G, Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry. 1993;150(5):763–9. doi: 10.1176/ajp.150.5.763 pmid: 8480823
41. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ, Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 1994;51(7):568–76. doi: 10.1001/archpsyc.1994.03950070060011 pmid: 8031230
42. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL, Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol. 2000;68(1):64–72. doi: 10.1037/0022-006X.68.1.64 pmid: 10710841
43. Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, et al. Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry. 2003;60(10):1043–52. doi: 10.1001/archpsyc.60.9.1043 pmid: 14557150
44. Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ, Schedule of voucher delivery influences initiation of cocaine abstinence. J Consult Clin Psychol. 1998;66(5):761–7. doi: 10.1037/0022-006X.66.5.761 pmid: 9803694
45. Landovitz RJ, Fletcher JB, Shoptaw S, Reback CJ, Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men. Open Forum Infect Dis. 2015;2(1):ofu114. doi: 10.1093/ofid/ofu114 pmid: 25884003
46. Ledgerwood DM, Petry NM, Does contingency management affect motivation to change substance use?Drug Alcohol Depend. 2006;83(1):65–72. doi: 10.1016/j.drugalcdep.2005.10.012 pmid: 16310974
47. Maude-Griffin PM, Hohenstein JM, Humfleet GL, Reilly PM, Tusel DJ, Hall SM, Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol. 1998;66(5):832–7. doi: 10.1037/0022-006X.66.5.832 pmid: 9803702
48. McDonell MG, Srebnik D, Angelo F, McPherson S, Lowe JM, Sugar A, et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. Am J Psychiatry. 2013;170(1):94–101. doi: 10.1176/appi.ajp.2012.11121831 pmid: 23138961
49. McKay JR, Alterman AI, Cacciola JS, Rutherford MJ, O’Brien CP, Koppenhaver J, Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. J Consult Clin Psychol. 1997;65(5):778–88. doi: 10.1037/0022-006X.65.5.778 pmid: 9337497
50. Menza TW, Jameson DR, Hughes JP, Colfax GN, Shoptaw S, Golden MR, Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. BMC Public Health. 2010;10:774. doi: 10.1186/1471-2458-10-774 pmid: 21172026
51. Miguel AQ, Madruga CS, Cogo-Moreira H, Yamauchi R, Simões V, da Silva CJ, et al. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: a randomized controlled trial. Psychol Addict Behav. 2016;30(5):536–43. doi: 10.1037/adb0000192 pmid: 27442691
52. Milby JB, Schumacher JE, Vuchinich RE, Freedman MJ, Kertesz S, Wallace D, Toward cost-effective initial care for substance-abusing homeless. J Subst Abuse Treat. 2008;34(2):180–91. doi: 10.1016/j.jsat.2007.03.003 pmid: 17512156
53. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry. 2006;63(2):201–8. doi: 10.1001/archpsyc.63.2.201 pmid: 16461864
54. Petitjean SA, Dursteler-MacFarland KM, Krokar MC, Strasser J, Mueller SE, Degen B, et al. A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence. Drug Alcohol Depend. 2014;145:94–100. doi: 10.1016/j.drugalcdep.2014.09.785 pmid: 25456571
55. Petry NM, Martin B, Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol. 2002;70(2):398–405. doi: 10.1037/0022-006X.70.2.398 pmid: 11952198
56. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005;62(10):1148–56. doi: 10.1001/archpsyc.62.10.1148 pmid: 16203960
57. Petry NM, Martin B, Simcic F, JrPrize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Clin Psychol. 2005;73(2):354–9. doi: 10.1037/0022-006X.73.2.354 pmid: 15796645
58. Petry NM, Alessi SM, Hanson T, Sierra S, Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. J Consult Clin Psychol. 2007;75(6):983–91. doi: 10.1037/0022-006X.75.6.983 pmid: 18085914
59. Petry NM, Alessi SM, Ledgerwood DM, A randomized trial of contingency management delivered by community therapists. J Consult Clin Psychol. 2012;80(2):286–98. doi: 10.1037/a0026826 pmid: 22250852
60. Petry NM, Barry D, Alessi SM, Rounsaville BJ, Carroll KM, A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol. 2012;80(2):276–85. doi: 10.1037/a0026883 pmid: 22229758
61. Petry NM, Alessi SM, Rash CJ, A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders. Drug Alcohol Depend. 2013;130(1–3):234–7. doi: 10.1016/j.drugalcdep.2012.10.017 pmid: 23182410
62. Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, et al. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006;63(2):219–28. doi: 10.1001/archpsyc.63.2.219 pmid: 16461866
63. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002;59(9):817–24. doi: 10.1001/archpsyc.59.9.817 pmid: 12215081
64. Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiberet C, A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction. 2006;101(2):267–74. doi: 10.1111/j.1360-0443.2006.01312.x pmid: 16445555
65. Roll JM, Chudzynski J, Cameron JM, Howell DN, McPherson S, Duration effects in contingency management treatment of methamphetamine disorders. Addict Behav. 2013;38(9):2455–62. doi: 10.1016/j.addbeh.2013.03.018 pmid: 23708468
66. Sánchez-Hervás E, Secades-Villa R, Romaguera FZ, García Fernández G, Santonja Gómez FJ, García-Rodríguez O, Behavioral therapy for cocaine addicts: outcomes of a follow-up six month study.] Rev Mex Psicol. 2010;27(2):159–67
67. Schottenfeld RS, Moore B, Pantalon MV, Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children. Drug Alcohol Depend. 2011;118(1):48–55. doi: 10.1016/j.drugalcdep.2011.02.019 pmid: 21454024
68. Secades-Villa R, Garcia-Fernandez G, Pena-Suarez E, Garcia-Rodriguez O, Sanchez-Hervas E, Fernandez-Hermida JR, Contingency management is effective across cocaine-dependent outpatients with different socioeconomic status. J Subst Abuse Treat. 2013;44(3):349–54. doi: 10.1016/j.jsat.2012.08.018 pmid: 22999380
69. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fullera E, Larkinset S, Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend. 2005;78(2):125–34. doi: 10.1016/j.drugalcdep.2004.10.004 pmid: 15845315
70. Shoptaw S, Reback CJ, Larkins S, Wang PC, Rotheram-Fuller E, Danget J, et al. Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men. J Subst Abuse Treat. 2008;35(3):285–93. doi: 10.1016/j.jsat.2007.11.004 pmid: 18329226
71. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996;53(5):409–15. doi: 10.1001/archpsyc.1996.01830050045007 pmid: 8624184
72. Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL, Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J Consult Clin Psychol. 1998;66(5):811–24. doi: 10.1037/0022-006X.66.5.811 pmid: 9803700
73. Smout MF, Longo M, Harrison S, Minniti R, Wickes W, White JM, Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and Acceptance and Commitment Therapy. Subst Abus. 2010;31(2):98–107. doi: 10.1080/08897071003641578 pmid: 20408061
74. Umbricht A, DeFulio A, Winstanley EL, Tompkins A, Peirce J, Mintzeret MZ, et al. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial. Drug Alcohol Depend. 2014;140:92–100. doi: 10.1016/j.drugalcdep.2014.03.033 pmid: 24814607
75. Ainscough TS, McNeill A, Strang J, Calder R, Brose LS, Contingency management interventions for non-prescribed drug use during treatment for opiate addiction: a systematic review and meta-analysis. Drug Alcohol Depend. 2017;178:318–39. doi: 10.1016/j.drugalcdep.2017.05.028 pmid: 28688295
76. Carroll KM, Weiss RD, The role of behavioral interventions in buprenorphine maintenance treatment: a review. Am J Psychiatry. 2017;174(8):738–47. doi: 10.1176/appi.ajp.2016.16070792 pmid: 27978771
77. Dallery J, Raiff BR, Kim SJ, Marsch LA, Stitzer M, Grabinski MJ, Nationwide access to an internet-based contingency management intervention to promote smoking cessation: a randomized controlled trial. Addiction. 2017;112(5):875–83. doi: 10.1111/add.13715 pmid: 27923264
78. Busch SH, Epstein AJ, Harhay MO, Fiellin DA, Un H, Leader D, Jret al. The effects of federal parity on substance use disorder treatment. Am J Manag Care. 2014;20(1):76–82. pmid: 24512166
79. Hui K, Angelotta C, Fisher CE, Criminalizing substance use in pregnancy: misplaced priorities. Addiction. 2017;112(7):1123–5. doi: 10.1111/add.13776 pmid: 28247578
80. Clark N, Dolan K, Farabee D, Public health alternatives to incarceration for drug offenders. East Mediterr Health J. 2017;23(3):222–30. pmid: 28493270
81. Ersche KD, Gillan CM, Jones PS, Williams GB, Ward LH, Luijten M, et al. Carrots and sticks fail to change behavior in cocaine addiction. Science. 2016;352(6292):1468–71. doi: 10.1126/science.aaf3700 pmid: 27313048
82. Carroll KM, Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice. Ann N Y Acad Sci. 2014;1327:94–111. doi: 10.1111/nyas.12501 pmid: 25204847
83. Luijten M, Schellekens AF, Kuhn S, Machielse MW, Sescousse G, Disruption of reward processing in addiction: an image-based meta-analysis of functional magnetic resonance imaging studies. JAMA Psychiatry. 2017;74(4):387–98. doi: 10.1001/jamapsychiatry.2016.3084 pmid: 28146248
84. Volkow ND, Koob GF, McLellan AT, Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–71. doi: 10.1056/NEJMra1511480 pmid: 26816013
85. Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–26. doi: 10.1111/add.14234 pmid: 29749059
86. Washington State Institute for Public Policy. Benefit-cost results. Olympia: Washington State Institute for Public Policy; 2017 [cited 2017 Aug 7]. http://www.wsipp.wa.gov/BenefitCost
87. Mark D, Luborsky L, Manual for the use of supportive-expressive psychotherapy in the treatment of cocaine abuse. Philadelphia (PA): University of Pennsylvania Department of Psychiatry; 1992